This announcement is a separate document:
大参林：大参林医药集团股份有限公司2022年半年度报告
Dashenlin: Dashenlin Pharmaceutical Group Co., Ltd. Semi-Annual Report 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.